Comparison of effects of TPVB and TIVA on platelet activation in patients with liver tumor after percutaneous radiofrequency ablation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023016

Enrollment

Unknown

Registered

2019-05-07

Start date

2019-05-15

Completion date

Unknown

Last updated

2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative liver tumor platelet function

Interventions

1:TPVB

2:TIVA

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18 to 75 years, weight 45 to 75 kg, operation time < 2 hours; (2) Signing informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients with local anesthetics and intravenous anesthetics; (2) Patients with thoracic surgery or thoracic disease; (3) Abnormal of coagulation function, platelet count and function; (4) With history of chronic pain before surgery and long-term use of anticoagulant, antiplatelet drugs and non-steroidal analgesics.

Design outcomes

Primary

Measure	Time frame
GMP-140;	—

Countries

China

Contacts

Public ContactXiaodan Wu

Department of Anaesthesiology, Fujian Provincial Hospital Jinshan Branch

119378547@qq.com+86 18046028248

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026